Prot # GS-US-367-1171:Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination for 12 Weeks in Direct-Acting Antiviral-Experienced Subjects with Chronic HCV Infectio

Project: Research project

Project Details

StatusFinished
Effective start/end date11/18/1511/18/18

Funding

  • PRA Health Sciences (GS-US-367-1171)
  • Gilead Sciences, Inc. (GS-US-367-1171)